These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35070012)

  • 1. Use of oral vancomycin in children with autoimmune liver disease: A single centre experience.
    Di Giorgio A; Tulone A; Nicastro E; Norsa L; Sonzogni A; D'Antiga L
    World J Hepatol; 2021 Dec; 13(12):2113-2127. PubMed ID: 35070012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary features in liver histology of children with autoimmune liver disease.
    Di Giorgio A; D'Adda A; Marseglia A; Sonzogni A; Licini L; Nicastro E; D'Antiga L
    Hepatol Int; 2019 Jul; 13(4):510-518. PubMed ID: 31069759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
    Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
    Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography.
    Gilligan LA; Trout AT; Lam S; Singh R; Tkach JA; Serai SD; Miethke AG; Dillman JR
    Abdom Radiol (NY); 2020 Jan; 45(1):168-176. PubMed ID: 31422438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune paediatric liver disease.
    Mieli-Vergani G; Vergani D
    World J Gastroenterol; 2008 Jun; 14(21):3360-7. PubMed ID: 18528933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune Sclerosing Cholangitis in Children: A Prospective Case-Control Study.
    Kumar N; Poddar U; Yadav R; Lal H; Pani K; Yachha SK; Srivastava A; Pandey R
    Pediatr Gastroenterol Hepatol Nutr; 2021 Mar; 24(2):154-163. PubMed ID: 33833971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis.
    Laschtowitz A; Zachou K; Lygoura V; Pape S; Derben F; Jaeckel E; Oller-Moreno S; Weidemann S; Krech T; Piecha F; Schön G; Liebhoff AM; Al Tarrah M; Heneghan M; Drenth JPH; Dalekos G; Taubert R; Lohse AW; Schramm C
    JHEP Rep; 2021 Aug; 3(4):100321. PubMed ID: 34381983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome.
    Di Giorgio A; Hadzic N; Dhawan A; Deheragoda M; Heneghan MA; Vergani D; Mieli-Vergani G; Samyn M
    J Pediatr; 2020 Mar; 218():121-129.e3. PubMed ID: 31955873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center.
    Singh H; Balouch F; Noble C; Lewindon P
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):80-85. PubMed ID: 29470284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune liver disease in children.
    Mieli-Vergani G; Vergani D
    Ann Acad Med Singap; 2003 Mar; 32(2):239-43. PubMed ID: 12772529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric Autoimmune Liver Disease.
    Liberal R; Vergani D; Mieli-Vergani G
    Dig Dis; 2015; 33 Suppl 2():36-46. PubMed ID: 26641670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric autoimmune liver disease and extra-hepatic immune-mediated comorbidities.
    Paolella G; Farallo M; Degrassi I; Agostoni C; Amoruso C; Nuti F; Nebbia G
    Dig Liver Dis; 2019 Feb; 51(2):281-285. PubMed ID: 30166220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune Liver Disease in Children with Sickle Cell Disease.
    Jitraruch S; Fitzpatrick E; Deheragoda M; Deganello A; Mieli-Vergani G; Height S; Rees D; Hadzic N; Samyn M
    J Pediatr; 2017 Oct; 189():79-85.e2. PubMed ID: 28735981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis.
    Biewenga M; Heidt S; Vergunst M; Marijnissen CMJ; de Man RA; van der Eijk AA; van der Meer AJ; Trouw LA; van Hoek B
    JHEP Rep; 2022 May; 4(5):100460. PubMed ID: 35368991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune sclerosing cholangitis: Evidence and open questions.
    Terziroli Beretta-Piccoli B; Vergani D; Mieli-Vergani G
    J Autoimmun; 2018 Dec; 95():15-25. PubMed ID: 30366655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.
    Deneau M; Jensen MK; Holmen J; Williams MS; Book LS; Guthery SL
    Hepatology; 2013 Oct; 58(4):1392-400. PubMed ID: 23686586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune hepatitis from the paediatric perspective.
    Roberts EA
    Liver Int; 2011 Nov; 31(10):1424-31. PubMed ID: 22093323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba.
    Fernández MIC; Hernández DR; Cabrera Eugenio DE; Palanca W; Guridi ZD; González Fabián L
    Curr Ther Res Clin Exp; 2017; 85():8-14. PubMed ID: 29158853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.